HER2 (ERBB2) alterations in colorectal cancers
Human epidermal growth factor receptor 2 / HER2 (erb-b2 receptor tyrosine kinase 2 / ERBB2) alterations are present in approximately 2-5% of metastatic colorectal cancers. Although, the full significance of the HER2 status in colorectal cancers is yet to be determined, the ongoing research revealed...
Saved in:
Main Authors: | Nika Tavberidze (Author), Wei Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023) -
Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors
by: Hao Wang, et al.
Published: (2022) -
Structural biology of HER2/ERBB2 dimerization: mechanistic insights and differential roles in healthy versus cancerous cells
by: Jayasree Santhanakrishnan, et al.
Published: (2024) -
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020) -
Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale
by: R. M. Paltuev, et al.
Published: (2023)